Jeffrey Raymond Balser
Engineering at Holly Rd, Brentwood, TN
License number
Louisiana EI.0009959
Issued Date
Jan 1, 1900
Expiration Date
Mar 31, 2009
Category
Civil Engineer
Address
Address
8218 Holly Rd, Brentwood, TN 37027
Professional information
Method Of Preventing And/Or Treating Oxidant Injury In Neurodegenerative And Oxidative Diseases
US Patent:
7705054, Apr 27, 2010
Filed:
Oct 20, 2005
Appl. No.:
11/254846
Inventors:
Jeffrey R. Balser - Brentwood TN, US
Sean S. Davies - Nashville TN, US
Prakash C. Viswanathan - Nashville TN, US
Venkataraman Amarnath - Nashville TN, US
Sean S. Davies - Nashville TN, US
Prakash C. Viswanathan - Nashville TN, US
Venkataraman Amarnath - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A01N 33/02, A61K 31/13
US Classification:
514649, 514659
Abstract:
A method of treating and/or preventing oxidative damage, comprising administering an effective IsoK/NeuroK adduct formation suppressing amount of a phenolic amine compound and/or pyridoxamine or pyridoxamine analog, including embodiments where the phenolic compound is at least one of a pyridoxamine, salicylamine, tyrosine compound or an analog thereof.
Isoketal Scavengers And Mitigation Of Disorders Involving Oxidative Injury
US Patent:
2012015, Jun 21, 2012
Filed:
Feb 27, 2009
Appl. No.:
12/395464
Inventors:
Jeffrey R. Balser - Brentwood TN, US
Sean S. Davies - Nashville TN, US
Venkataraman Amarnath - Nashville TN, US
Prakash C. Viswanathan - Chesapeake VA, US
Sean S. Davies - Nashville TN, US
Venkataraman Amarnath - Nashville TN, US
Prakash C. Viswanathan - Chesapeake VA, US
International Classification:
A61K 31/44, A61K 31/135, A61P 25/00, A61K 31/195
US Classification:
514351, 514567, 514655
Abstract:
A method of treating and/or preventing oxidative damage, comprising administering an effective IsoK/NeuroK adduct formation suppressing amount of a phenolic amine compound and/or pyridoxamine or pyridoxamine analog, including embodiments where the phenolic compound is at least one of a pyridoxamine, salicylamine, tyrosine compound or an analog thereof.
Human Kcr1 Regulation Of Herg Potassium Channel Block
US Patent:
2003001, Jan 16, 2003
Filed:
Oct 30, 2001
Appl. No.:
10/000151
Inventors:
Jeffrey Balser - Brentwood TN, US
Alfred George - Brentwood TN, US
Dan Roden - Nashville TN, US
Alfred George - Brentwood TN, US
Dan Roden - Nashville TN, US
International Classification:
G01N033/567, C12Q001/68, C12P021/02, C12N005/06, C12N015/85
US Classification:
435/007210, 435/006000, 435/455000, 435/325000
Abstract:
The present invention discloses methods relating to screening methods and methods of identifying a compound that can modulate HERG potassium channel activity. The methods generally employ at least HERG and KCR1 polypeptides. The disclosed methods can be applied in the development of a candidate pharmaceutical or they can be employed to evaluate presently marketed pharmaceuticals.